Cargando…
Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants
BACKGROUND: Neurological manifestations and the co-occurrence of multiple sclerosis (MS) have been reported in patients with autoinflammatory diseases (AID) and variants of the NLRP3-, MEFV-, or TNFRSF1A gene. However, type and frequency of neurological involvement are widely undetermined. METHODS:...
Autores principales: | Mulazzani, Elisabeth, Wagner, Danny, Havla, Joachim, Schlüter, Miriam, Meinl, Ingrid, Gerdes, Lisa-Ann, Kümpfel, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306142/ https://www.ncbi.nlm.nih.gov/pubmed/32563262 http://dx.doi.org/10.1186/s12974-020-01867-5 |
Ejemplares similares
-
Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts
por: Schlüter, Miriam, et al.
Publicado: (2021) -
Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations
por: Schuh, Elisabeth, et al.
Publicado: (2015) -
Neurological manifestations in autoinflammatory syndromes: a series of 131 patients from our neuroimmunology departement
por: Schuh, E, et al.
Publicado: (2015) -
Next-Generation Sequencing Analysis of MVK, NLRP3, TNFRSF1A, and PSTPIP1 Genes in Patients without MEFV Gene Variation and Genotype–Phenotype Correlation
por: Vuran, Gamze, et al.
Publicado: (2022) -
Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?
por: Havla, Joachim, et al.
Publicado: (2013)